Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Prevalence of Diabetes in India: A Review of IDF Diabetes Atlas 10th Edition

Author(s): Arvind Kumar, Ruby Gangwar, Abrar Ahmad Zargar, Ranjeet Kumar* and Amit Sharma

Volume 20, Issue 1, 2024

Published on: 19 May, 2023

Article ID: e130423215752 Pages: 10

DOI: 10.2174/1573399819666230413094200

Price: $65

conference banner
Abstract

Diabetes is a severe chronic disease that arises when insulin generation is insufficient, or the generated insulin cannot be used in the body, resulting a long-term metabolic disorder. Diabetes affects an estimated 537 million adults worldwide between the age of 20 to 79 (10.5% of all adults in this age range). By 2030, 643 million people will have diabetes globally, increasing to 783 million by 2045. According to the IDF 10th edition, the incidence of diabetes has been rising in South-East Asia (SEA) nations for at least 20 years, and current estimates have outperformed all previous forecasts. This review aims to provide updated estimates and future projections of diabetes prevalence at the national and global levels by using data from the 10th edition of the IDF Diabetes Atlas 2021. For this review, we studied more than 60 previously published related articles from various sources, such as PubMed and Google Scholar, and we extracted 35 studies out of 60. however, we used only 34 studies directly related to diabetes and its prevalence at the global, SEA, and Indian levels. This review article concludes that in 2021 more than 1 in 10 adults worldwide developed diabetes. The estimated prevalence of diabetes in adults (20 to 79 years) has more than tripled since the first edition in 2000, rising from an estimated 151 million (4.6% of the world’s population at the time) to 537.5 million (10.5%) of the world’s population today. The prevalence rate will be higher than 12.8% by 2045. In addition, this study indicates that the incidence of diabetes in the world, Southeast Asia, and India was 10.5%, 8.8%, and 9.6%, respectively, throughout 2021 and will rise to 12.5%, 11.5%, and 10.9%, respectively by 2045.

[1]
Federation ID. IDF Diabetes Atlas Tenth 2021. Accessed on 10th July 2022
[2]
Steiner DF, Park SY, Støy J, Philipson LH, Bell GI. A brief perspective on insulin production. Diabetes Obes Metab 2009; 11 (Suppl. 4): 189-96.
[http://dx.doi.org/10.1111/j.1463-1326.2009.01106.x] [PMID: 19817801]
[3]
Ogle GD. Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas. Diabetes Res Clin Pract 2022; 183: 109083.
[http://dx.doi.org/10.1016/j.diabres.2021.109083] [PMID: 34883188]
[4]
Tuomilehto J, Ogle GD, Lund-Blix NA, Stene LC. Update on Worldwide trends in occurrence of childhood type 1 diabetes in 2020. Pediatr Endocrinol Rev 2020; 17 (Suppl. 1): 198-209.
[PMID: 32208564]
[5]
Gucciardi E, Wang SCT, DeMelo M, Amaral L, Stewart DE. Characteristics of men and women with diabetes: Observations during patients’ initial visit to a diabetes education centre. Can Fam Physician 2008; 54(2): 219-27.
[PMID: 18272638]
[6]
Al-Shihabi F, Moore A, Chowdhury TA. Diabetes and climate change. Diabet Med 2023; 40(3): e14971.
[http://dx.doi.org/10.1111/dme.14971] [PMID: 36209378]
[7]
Ling C, Groop L. Epigenetics: A molecular link between environmental factors and type 2 diabetes. Diabetes 2009; 58(12): 2718-25.
[http://dx.doi.org/10.2337/db09-1003] [PMID: 19940235]
[8]
Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes: A statement of the American Diabetes Association. Diabetes Care 2005; 28(1): 186-212.
[http://dx.doi.org/10.2337/diacare.28.1.186] [PMID: 15616254]
[9]
Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94(3): 311-21.
[http://dx.doi.org/10.1016/j.diabres.2011.10.029] [PMID: 22079683]
[10]
Guariguata L, Whiting D, Weil C, Unwin N. The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. Diabetes Res Clin Pract 2011; 94(3): 322-32.
[http://dx.doi.org/10.1016/j.diabres.2011.10.040] [PMID: 22100977]
[11]
Basu Sanjay. The relationship of sugar to population-level diabetes prevalence: An econometric analysis of repeated cross-sectional data. PloS one 2013; 8.2: e57873.
[http://dx.doi.org/10.1371/journal.pone.0057873]
[12]
Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014; 103(2): 176-85.
[http://dx.doi.org/10.1016/j.diabres.2013.11.003] [PMID: 24300020]
[13]
World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy 2013. Available from: tedebc.ufma.br
[14]
Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care #. Int J Gynaecol Obstet 2015; 131: S173-211.
[http://dx.doi.org/10.1016/S0020-7292(15)30033-3]
[15]
2015. Available from: file:///D:/dowanloads/9789241515702-eng.pdf
[16]
Saeedi Pouya. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice 2019; 157: 107843.
[http://dx.doi.org/10.1016/j.diabres.2019.107843]
[17]
Sun H. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119.
[18]
Ogurtsova K, Guariguata L, Barengo NC, et al. IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract 2022; 183: 109118.
[http://dx.doi.org/10.1016/j.diabres.2021.109118] [PMID: 34883189]
[19]
Immanuel J, Simmons D. Screening and treatment for early-onset gestational diabetes mellitus: A systematic review (doi.org) and meta-analysis. Curr Diab Rep 2017; 17(11): 115.
[http://dx.doi.org/10.1007/s11892-017-0943-7] [PMID: 28971305]
[20]
King Hilary, Aubert Ronald E, Herman William H. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21(9): 1414-31.
[http://dx.doi.org/10.2337/diacare.21.9.1414]
[21]
Kautzky-Willer A, Abrahamian H, Weitgasser R, Fasching P, Hoppichler F, Lechleitner M. Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes. Wien Klin Wochenschr 2016; 128(S2): 151-8.
[http://dx.doi.org/10.1007/s00508-016-0957-1] [PMID: 27052235]
[22]
Ramachandran A, Snehalatha C, Ma RCW. Diabetes in south-east Asia: An update. Diabetes Res Clin Pract 2014; 103(2): 231-7.
[http://dx.doi.org/10.1016/j.diabres.2013.11.011] [PMID: 24300015]
[23]
World Population Review. India Population 2022. Available from: https://worldpopulationreview.com/countries/india-population
[24]
http://diabetesindia.com/diabetes-causes-preventions/open-house/history-of-diabetes/history-of-diabetes.htmlAccessed on 19th July 2022
[25]
Atre S. Addressing policy needs for prevention and control of type 2 diabetes in India. Perspect Public Health 2015; 135(5): 257-63.
[http://dx.doi.org/10.1177/1757913914565197] [PMID: 25585513]
[26]
Atre Sachin. The burden of diabetes in India. The Lancet Global Health 2019; 7(4): E418.
[http://dx.doi.org/10.1016/S2214-109X(18)30556-4]
[27]
Chandranand PS, Sowjanya L. Review on non-communicable diseases in india and their respective diagnostic platforms International Journal of Applied Science and Engineering 2021; 9(11) https://www.researchgate.net/publication/356728360_Review_on_Non-Communicable_Diseases_in_India_and_their_Respective_Diagnostic_Platforms. Accessed on 15th July 2022
[http://dx.doi.org/10.22214/ijraset.2021.39024]
[28]
Anjana Ranjit Mohan. The Indian Council of Medical Research—India Diabetes (ICMR-INDIAB) Study: Methodological details. J Diabetes Sci Technol 2011; 5(4): 906-14.
[http://dx.doi.org/10.1177/193229681100500413]
[29]
Anjana RM, Deepa M, Pradeepa R, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. The lancet Diabetes & endocrinology 2017 Aug 1; 5(8): 585-96.
[30]
Mathur P, Leburu S, Kulothungan V. Prevalence, awareness, treatment and control of diabetes in india from the countrywide national NCD monitoring survey. Front Public Health 2022; 10: 748157.
[http://dx.doi.org/10.3389/fpubh.2022.748157] [PMID: 35359772]
[31]
Federation, International Diabetes. IDF Diabetes Atlas Seven Edition. In: International Diabetes Federation (IDF) 2015.
[32]
Federation, International Diabetes. IDF diabetes atlas 8th edition. In: International diabetes federation 2017; pp. 905-11.
[33]
Atlas D. IDF diabetes atlas 9th ed International Diabetes Federation. 2019. Available from: http://www. idf. org/about-diabetes/facts-figures

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy